In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.
In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.
复制标题
DOI:
10.1016/j.mcpro.2021.100081
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Li L
中科院分区:
文献类型:
--
作者:
Chen Z;Yu Q;Yu Q;Johnson J;Shipman R;Zhong X;Huang J;Asthana S;Carlsson C;Okonkwo O;Li L
As the body fluid that directly interchanges with the extracellular fluid of the central nervous system (CNS), cerebrospinal fluid (CSF) serves as a rich source for CNS-related disease biomarker discovery. Extensive proteome profiling has been conducted for CSF, but studies aimed at unraveling site-specific CSF N-glycoproteome are lacking. Initial efforts into site-specific N-glycoproteomics study in CSF yield limited coverage, hindering further experimental design of glycosylation-based disease biomarker discovery in CSF. In the present study, we have developed an N-glycoproteomic approach that combines enhanced N-glycopeptide sequential enrichment by hydrophilic interaction chromatography (HILIC) and boronic acid enrichment with electron transfer and higher-energy collision dissociation (EThcD) for large-scale intact N-glycopeptide analysis. The application of the developed approach to the analyses of human CSF samples enabled identifications of a total of 2893 intact N-glycopeptides from 511 N-glycosites and 285 N-glycoproteins. To our knowledge, this is the largest site-specific N-glycoproteome dataset reported for CSF to date. Such dataset provides molecular basis for a better understanding of the structure–function relationships of glycoproteins and their roles in CNS-related physiological and pathological processes. As accumulating evidence suggests that defects in glycosylation are involved in Alzheimer's disease (AD) pathogenesis, in the present study, a comparative in-depth N-glycoproteomic analysis was conducted for CSF samples from healthy control and AD patients, which yielded a comparable N-glycoproteome coverage but a distinct expression pattern for different categories of glycoforms, such as decreased fucosylation in AD CSF samples. Altered glycosylation patterns were detected for a number of N-glycoproteins including alpha-1-antichymotrypsin, ephrin-A3 and carnosinase CN1 etc., which serve as potentially interesting targets for further glycosylation-based AD study and may eventually lead to molecular elucidation of the role of glycosylation in AD progression. Efficient N-glycopeptide sequential enrichment by HILIC and boronic acid enrichment. Site-specific intact N-glycopeptide characterization using EThcD. In-depth site-specific N-glycoproteome analysis in human CSF. Mapping the landscape of glycosylation patterns in Alzheimer's disease. An exploratory glycosylation-based biomarker study has been conducted for in-depth mapping of an overall glycosylation landscape and site-specific alteration in glycoproteome collected from cerebrospinal fluids (CSF) in healthy control and Alzheimer’s disease (AD) subjects. The comparison will shed light on the glycoproteome profile, dominant glycosylation differences and similarities, and some of the interesting glycoprotein candidates with specific glycosylation pattern alterations in AD.
登录
查看更多内容
影响因子:
7.8
作者:
Chen Z;Glover MS;Li L
通讯作者:
Li L
影响因子:
16.2
作者:
Bai, Bing;Wang, Xusheng;Peng, Junmin
通讯作者:
Peng, Junmin
影响因子:
2.3
作者:
Cunningham, Robert;Wang, Jingxin;Li, Lingjun
通讯作者:
Li, Lingjun
影响因子:
4.4
作者:
Bern, Marshall W.;Kil, Yong J.
通讯作者:
Kil, Yong J.
DOI:
10.1074/mcp.m111.011601
发表时间:
2012-09
期刊:
Molecular & cellular proteomics : MCP
影响因子:
--
作者:
Balog CI;Stavenhagen K;Fung WL;Koeleman CA;McDonnell LA;Verhoeven A;Mesker WE;Tollenaar RA;Deelder AM;Wuhrer M
通讯作者:
Wuhrer M